Open Content License under Swiss Law (Open Content Lizenz Nach Schweizerischem Recht)

2004 ◽  
Author(s):  
Urs Gehrig
Keyword(s):  
Swiss Law ◽  
Open Content

scholarly journals Treasuring and preserving languages: how the inclusive design in MOOCs might help

2020 ◽  
pp. 5-12
Author(s):  
Kate Borthwick
Keyword(s):  
Professional Development ◽  
Language Learning ◽  
Online Courses ◽  
Massive Open Online Courses ◽  
Inclusive Design ◽  
Learning Contexts ◽  
Barriers To Access ◽  
Open Content ◽  
The University ◽  
Development Course

This paper reflects on the inclusive design features of Massive Open Online Courses (MOOCs) and how these might support and encourage language learning. It considers what inclusivity in the context of MOOCs means, and some of the features of MOOCs which might be inherently inclusive and of value in supporting languages. It presents an example of inclusive design from a MOOC created at the University of Southampton: English as a Medium of Instruction (EMI) for Academics, a professional development course for teachers. It shows how this course was particularly designed to appeal to the broadest audience possible, and indicates how this might be relevant in language learning contexts. It considers the challenges of creating inclusive open content, and how MOOC design encourages the treasuring and preserving of languages through global reach and low barriers to access.

scholarly journals Restriction on the Authority to Represent in Turkish Joint Stock Companies Law

2019 ◽  
Vol 2 (3) ◽  
pp. 58
Author(s):  
Sıtkı Anlam Altay
Keyword(s):  
Critical View ◽  
Commercial Code ◽  
Swiss Law ◽  
Turkish Commercial Code

Turkish Joint Stock Corporations Law is based upon Swiss Law. Turkish Commercial Code of 2012 reflects a pure reception of the rules regarding the representation of the company from Swiss Law. However in 2014, Turkish Law has confronted the enforcement of Art. 371/7 TCC, which enables restrictions on the representation authority in terms of the material and monetary scope of the transaction. This study aims to bring a critical view of this regulation and to introduce a draft for a well-directed regulation with respect to restrictions related to power of representation.

The Swiss Regulatory Framework for Paediatric Health Research

2008 ◽  
Vol 15 (2) ◽  
pp. 183-195
Author(s):  
Valerie Junod
Keyword(s):  
Clinical Trials ◽  
Health Research ◽  
Ethics Committees ◽  
Drug Trials ◽  
Pharmaceutical Firms ◽  
Risks And Benefits ◽  
Drug Agency ◽  
Swiss Law ◽  
Broad Array ◽  
Paediatric Health

AbstractMedical research on minors entails both risks and benefits. Under Swiss law, clinical trials on children, including nontherapeutic drug trials, are permissible. However, ethics committees must systematically verify that all clinical studies have a favorable risk-benefit profile. Additional safeguards are designed to ensure that children are not unnecessarily involved in research and that proper consent is always obtained. Federal Swiss law is undergoing revision to extend these protections beyond clinical trials to a broad array of health research. The Swiss drug agency also seeks to improve the incentives for pharmaceutical firms to develop new paediatric drugs and relevant paediatric drug labels.

Sign in / Sign up

Export Citation Format

Share Document